AI assistant
FIBROGEN INC — Director's Dealing 2023
Mar 11, 2023
34576_dirs_2023-03-10_24074fca-b519-4367-a795-428949dad170.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2023-03-08
Reporting Person: Eisner Mark (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-03-08 | Common Stock | S | 7363 | $21.1559 | Disposed | 165133 | Direct |
| 2023-03-08 | Common Stock | A | 7732 | $0.00 | Acquired | 172865 | Direct |
| 2023-03-08 | Common Stock | A | 12451 | $0.00 | Acquired | 185316 | Direct |
| 2023-03-10 | Common Stock | S | 3885 | $20.1973 | Disposed | 181431 | Direct |
| 2023-03-10 | Common Stock | S | 6255 | $20.1973 | Disposed | 175176 | Direct |
Footnotes
F1: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.
F2: Represents the number of shares released for PSU Milestone Grant vested on March 8, 2023.
F3: Represents the number of shares released for PSU TSR Grant vested on March 8, 2023.
F4: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of PSU Milestone previously reported in Table I.
F5: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of PSU TSR previously reported in Table I.